All Stories

  1. Repurposing polyamines to prevent life-threatening arrhythmias in Short QT Syndrome type 3
  2. NOD1 is a key mediator of atrial myopathy in heart failure
  3. Ventricular fibrillation dynamics reveal regional asymmetry in resilience to cardiac arrest and predict clinical outcome
  4. Rescuing the heart from the tornadoes of sudden cardiac death
  5. Lgi3-4 proteins modulate the KV1.5 channelosome and are potential therapeutic targets for atrial fibrillation
  6. Cardiac Macrophages and Fibroblasts Modulate Atrial Fibrillation Maintenance
  7. The Complex Interplay Between Aging, Cardiac Remodeling, and Atrial Fibrillation
  8. MOG1 L18F -mediated increase in late sodium current produces Long QT Syndrome
  9. Transforming atrial fibrillation management by targeting comorbidities and reducing atrial fibrillation burden: the 10th AFNET/EHRA consensus conference
  10. Investigating the Risk of Arrhythmogenesis Associated With Fentanyl Abuse Using Human and Mouse Cardiomyocytes
  11. Ion channel traffic jams: the significance of trafficking deficiency in long QT syndrome
  12. Promising tools for future drug discovery and development in antiarrhythmic therapy
  13. Kir2.1 mutations differentially increase the risk of flecainide proarrhythmia in Andersen Tawil Syndrome
  14. The G4 resolvase Dhx36 modulates cardiomyocyte differentiation and ventricular conduction system development
  15. The Impact of Extracellular Histones and Absence of Toll-like Receptors on Cardiac Functional and Electrical Disturbances in Mouse Hearts
  16. Practical approach for atrial cardiomyopathy characterization in patients with atrial fibrillation
  17. Atrial cardiomyopathy revisited—evolution of a concept: a clinical consensus statement of the European Heart Rhythm Association (EHRA) of the ESC, the Heart Rhythm Society (HRS), the Asian Pacific Heart Rhythm Society (APHRS), and the Latin American He...
  18. Extracellular Kir2.1 C122Y Mutant Upsets Kir2.1-PIP 2 Bonds and Is Arrhythmogenic in Andersen-Tawil Syndrome
  19. The Kir2.1-NaV1.5 Channelosome and its role in Arrhythmias in Inheritable Cardiac Diseases
  20. p38γ/δ activation alters cardiac electrical activity and predisposes to ventricular arrhythmia
  21. Intermediate Molecular Phenotypes to Identify Genetic Markers of Anthracycline-Induced Cardiotoxicity Risk
  22. SNTA1 Gene Rescues Ion Channel Function in Cardiomyocytes Derived from Induced Pluripotent Stem Cells Reprogrammed from Muscular Dystrophy Patients with Arrhythmias
  23. Erratum to: Transcriptome and proteome mapping in the sheep atria reveal molecular features of atrial fibrillation progression
  24. Mapping Technologies for Catheter Ablation of Atrial Fibrillation Beyond Pulmonary Vein Isolation
  25. Novel approaches to mechanism-based atrial fibrillation ablation
  26. Paclitaxel mitigates structural alterations and cardiac conduction system defects in a mouse model of Hutchinson–Gilford progeria syndrome
  27. Cardiac phenotype in familial partial lipodystrophy
  28. Tbx5 variants disrupt Nav1.5 function differently in patients diagnosed with Brugada or Long QT Syndrome
  29. Anatomical targets and expected outcomes of catheter‐based ablation of atrial fibrillation in 2020
  30. Transcriptome and proteome mapping in the sheep atria reveal molecular featurets of atrial fibrillation progression
  31. Kir2.1 Interactome Mapping Uncovers PKP4 as a Modulator of the Kir2.1-Regulated Inward Rectifier Potassium Currents
  32. The p.P888L SAP97 polymorphism increases the transient outward current (Ito,f) and abbreviates the action potential duration and the QT interval
  33. Human influenza A virus causes myocardial and cardiac-specific conduction system infections associated with early inflammation and premature death
  34. Personalized monitoring of electrical remodelling during atrial fibrillation progression via remote transmissions from implantable devices
  35. Use of Human Induced Pluripotent Stem Cell–Derived Cardiomyocytes in Preclinical Cancer Drug Cardiotoxicity Testing: A Scientific Statement From the American Heart Association
  36. Mechanisms by Which Ranolazine Terminates Paroxysmal but Not Persistent Atrial Fibrillation
  37. Atrial Myopathy
  38. Instantaneous Amplitude and Frequency Modulations Detect the Footprint of Rotational Activity and Reveal Stable Driver Regions as Targets for Persistent Atrial Fibrillation Ablation
  39. A computational model of induced pluripotent stem‐cell derived cardiomyocytes incorporating experimental variability from multiple data sources
  40. Functional cardiac fibroblasts derived from human pluripotent stem cells via second heart field progenitors
  41. Lesion Index Titration Using Contact-Force Technology Enables Safe and Effective Radiofrequency Lesion Creation at the Root of the Aorta and Pulmonary Artery
  42. Clinical Characteristics and Electrophysiological Mechanisms Underlying Brugada ECG in Patients With Severe Hyperkalemia
  43. Three-dimensional cardiac fibre disorganization as a novel parameter for ventricular arrhythmia stratification after myocardial infarction
  44. Brugada syndrome trafficking–defective Nav1.5 channels can trap cardiac Kir2.1/2.2 channels
  45. Implications of bipolar voltage mapping and magnetic resonance imaging resolution in biventricular scar characterization after myocardial infarction
  46. Biobank-driven genomic discovery yields new insight into atrial fibrillation biology
  47. Mechanisms and Drug Development in Atrial Fibrillation
  48. Cardiac Kir2.1 and Na V 1.5 Channels Traffic Together to the Sarcolemma to Control Excitability
  49. Factors affecting basket catheter detection of real and phantom rotors in the atria: A computational study
  50. The tornadoes of sudden cardiac arrest
  51. Causality analysis of leading singular value decomposition modes identifies rotor as the dominant driving normal mode in fibrillation
  52. Genome-wide Study of Atrial Fibrillation Identifies Seven Risk Loci and Highlights Biological Pathways and Regulatory Elements Involved in Cardiac Development
  53. Eplerenone Reduces Atrial Fibrillation Burden Without Preventing Atrial Electrical Remodeling
  54. Structural basis for the antiarrhythmic blockade of a potassium channel with a small molecule
  55. Synergistic Research Between the Center of Arrhythmia Research and the Michigan Biology of Cardiovascular Aging at the University of Michigan
  56. Triple threat: adiposity, aging, atrial fibrillation
  57. hiPSC-CM Monolayer Maturation State Determines Drug Responsiveness in High Throughput Pro-Arrhythmia Screen
  58. 2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation: Executive summary
  59. 2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation
  60. 2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation: Executive summary
  61. 2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation
  62. 2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation: Executive summary
  63. 2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation: executive summary
  64. Propagation of Sinus Waves in the Atrial Architecture
  65. Is TGF-β 1 (Transforming Growth Factor-β 1 ) an Enabler of Myofibroblast–Cardiomyocyte Cross Talk?
  66. Selection of the Best of 2016 in Catheter Ablation
  67. Tbx20 controls the expression of the KCNH2 gene and of hERG channels
  68. EHRA/HRS/APHRS/SOLAECE expert consensus on atrial cardiomyopathies: Definition, characterization, and clinical implication
  69. Deficient cMyBP-C protein expression during cardiomyocyte differentiation underlies human hypertrophic cardiomyopathy cellular phenotypes in disease specific human ES cell derived cardiomyocytes
  70. Complement Destabilizes Cardiomyocyte Function In Vivo after Polymicrobial Sepsis and In Vitro
  71. Dynamics and Molecular Mechanisms of Ventricular Fibrillation in Structurally Normal Hearts
  72. EHRA/HRS/APHRS/SOLAECE expert consensus on atrial cardiomyopathies: definition, characterization, and clinical implication
  73. Mutated KCNJ5 activates the acute and chronic regulatory steps in aldosterone production
  74. Constitutive Intracellular Na + Excess in Purkinje Cells Promotes Arrhythmogenesis at Lower Levels of Stress Than Ventricular Myocytes From Mice With Catecholaminergic Polymorphic Ventricular Tachycardia
  75. Atrial Fibrillation Susceptibility in Obesity
  76. Extracellular Matrix–Mediated Maturation of Human Pluripotent Stem Cell–Derived Cardiac Monolayer Structure and Electrophysiological Function
  77. Galectin-3 Regulates Atrial Fibrillation Remodeling and Predicts Catheter Ablation Outcomes
  78. Mechanisms of Atrial Fibrillation
  79. Novel Upstream Approaches to Prevent Atrial Fibrillation Perpetuation
  80. Pulmonary vein triggers, focal sources, rotors and atrial cardiomyopathy: implications for the choice of the most effective ablation therapy
  81. Structural and Functional Bases of Cardiac Fibrillation
  82. Nav1.5 N-terminal domain binding to α1-syntrophin increases membrane density of human Kir2.1, Kir2.2 and Nav1.5 channels
  83. Mechanistic Approaches to Detect, Target, and Ablate the Drivers of Atrial Fibrillation
  84. Atrial fibrillation is associated with the fibrotic remodelling of adipose tissue in the subepicardium of human and sheep atria
  85. The elusive rotor electrogram footprint
  86. Letter by Jalife et al Regarding Article, “Quantitative Analysis of Localized Sources Identified by Focal Impulse and Rotor Modulation Mapping in Atrial Fibrillation”
  87. Ventricular Tachycardia and Early Fibrillation in Patients With Brugada Syndrome and Ischemic Cardiomyopathy Show Predictable Frequency-Phase Properties on the Precordial ECG Consistent With the Respective Arrhythmogenic Substrate
  88. Atrial remodeling, fibrosis, and atrial fibrillation
  89. Protein assemblies of sodium and inward rectifier potassium channels control cardiac excitability and arrhythmogenesis
  90. Ion Channel Macromolecular Complexes in Cardiomyocytes: Roles in Sudden Cardiac Death
  91. Spectral analysis-based risk score enables early prediction of mortality and cerebral performance in patients undergoing therapeutic hypothermia for ventricular fibrillation and comatose status
  92. Arrhythmogenesis in a catecholaminergic polymorphic ventricular tachycardia mutation that depresses ryanodine receptor function
  93. A device for rapid and quantitative measurement of cardiac myocyte contractility
  94. Role of extracellular histones in the cardiomyopathy of sepsis
  95. Comparison of Radiofrequency Catheter Ablation of Drivers and Circumferential Pulmonary Vein Isolation in Atrial Fibrillation
  96. Spectral analysis of electrograms in a substrate modified by radiofrequency ablation reveals similarities between organized and disorganized atrial rhythms
  97. Mechanisms of Atrial Fibrillation
  98. Novel Upstream Approaches to Prevent Atrial Fibrillation Perpetuation
  99. Scn1b deletion leads to increased tetrodotoxin‐sensitive sodium current, altered intracellular calcium homeostasis and arrhythmias in murine hearts
  100. CrossTalk proposal: Rotors have been demonstrated to drive human atrial fibrillation
  101. Rebuttal from Sanjiv M. Narayan and José Jalife
  102. Dominant Frequency Increase Rate Predicts Transition from Paroxysmal to Long-Term Persistent Atrial Fibrillation
  103. Mechanisms of persistent atrial fibrillation
  104. Myosin light chain 2-based selection of human iPSC-derived early ventricular cardiac myocytes
  105. Modulated parasystole: Still relevant after all these years!
  106. And the beat goes on ... the beat goes on: organization and quasi-periodicity in ventricular fibrillation
  107. Inhibition of platelet-derived growth factor-AB signaling prevents electromechanical remodeling of adult atrial myocytes that contact myofibroblasts
  108. Neuroanatomy of the murine cardiac conduction system
  109. Nerves projecting from the intrinsic cardiac ganglia of the pulmonary veins modulate sinoatrial node pacemaker function
  110. Noninvasive Localization of Maximal Frequency Sites of Atrial Fibrillation by Body Surface Potential Mapping
  111. Introduction to the Series on Computational Approaches to Cardiac Arrhythmias
  112. Mechanoelectric Feedback in the Ischemic Myocardium: An Interplay That Modulates Susceptibility to Fibrillation
  113. Rotors and the Dynamics of Cardiac Fibrillation
  114. KCNJ2 mutation in short QT syndrome 3 results in atrial fibrillation and ventricular proarrhythmia
  115. Genetically Engineered Excitable Cardiac Myofibroblasts Coupled to Cardiomyocytes Rescue Normal Propagation and Reduce Arrhythmia Complexity in Heterocellular Monolayers
  116. TGF-β1, Released by Myofibroblasts, Differentially Regulates Transcription and Function of Sodium and Potassium Channels in Adult Rat Ventricular Myocytes
  117. Heterogeneity of Ryanodine Receptor Dysfunction in a Mouse Model of Catecholaminergic Polymorphic Ventricular Tachycardia
  118. The ionic bases of the action potential in isolated mouse cardiac Purkinje cell
  119. Long-Term Frequency Gradients During Persistent Atrial Fibrillation in Sheep Are Associated With Stable Sources in the Left Atrium
  120. Translational Research in Atrial Fibrillation
  121. Spatial gradients in action potential duration created by regional magnetofection of hERG are a substrate for wavebreak and turbulent propagation in cardiomyocyte monolayers
  122. Extracellular Matrix Promotes Highly Efficient Cardiac Differentiation of Human Pluripotent Stem Cells
  123. Elevated Pre-Operative Serum Peptides for Collagen I and III Synthesis Result in Post-Surgical Atrial Fibrillation
  124. Venice Chart International Consensus Document on Atrial Fibrillation Ablation: 2011 Update
  125. Biological pacemakers: The oscillatory road ahead
  126. High-rate pacing-induced atrial fibrillation effectively reveals properties of spontaneously occurring paroxysmal atrial fibrillation in humans
  127. Simultaneous Voltage and Calcium Mapping of Genetically Purified Human Induced Pluripotent Stem Cell–Derived Cardiac Myocyte Monolayers
  128. Chloroquine Terminates Stretch-Induced Atrial Fibrillation More Effectively Than Flecainide in the Sheep Heart
  129. Dynamic reciprocity of sodium and potassium channel expression in a macromolecular complex controls cardiac excitability and arrhythmia
  130. 2012 HRS/EHRA/ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation: Recommendations for Patient Selection, Procedural Techniques, Patient Management and Follow-up, Definitions, Endpoints, and Research Trial Design
  131. Radiofrequency catheter ablation of pulmonary vein roots results in axonal degeneration of distal epicardial nerves
  132. 2012 HRS/EHRA/ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation: Recommendations for Patient Selection, Procedural Techniques, Patient Management and Follow-up, Definitions, Endpoints, and Research Trial Design: A...
  133. 2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design
  134. Optical Imaging of Voltage and Calcium in Cardiac Cells & Tissues
  135. Regional cooling facilitates termination of spiral-wave reentry through unpinning of rotors in rabbit hearts
  136. Left-to-right ventricular differences in IKATP underlie epicardial repolarization gradient during global ischemia
  137. Time- and frequency-domain analyses of atrial fibrillation activation rate: The optical mapping reference
  138. Human Atrial Action Potential and Ca 2+ Model
  139. Minimum Information about a Cardiac Electrophysiology Experiment (MICEE): Standardised reporting for model reproducibility, interoperability, and data sharing
  140. A null mutation of the neuronal sodium channel Na V 1.6 disrupts action potential propagation and excitation‐contraction coupling in the mouse heart
  141. Complex Fractionated Atrial Electrograms
  142. High-Resolution Endocardial and Epicardial Optical Mapping in a Sheep Model of Stretch-Induced Atrial Fibrillation
  143. Guidance for the Heart Rhythm Society Pertaining to Interactions with Industry
  144. Loss of H3K4 methylation destabilizes gene expression patterns and physiological functions in adult murine cardiomyocytes
  145. Immunohistochemical characterization of the intrinsic cardiac neural plexus in whole-mount mouse heart preparations
  146. Mammalian enabled (Mena) is a critical regulator of cardiac function
  147. Structural heterogeneity promotes triggered activity, reflection and arrhythmogenesis in cardiomyocyte monolayers
  148. Complement dependency of cardiomyocyte release of mediators during sepsis
  149. Morphologic pattern of the intrinsic ganglionated nerve plexus in mouse heart
  150. Left atrial pressure and dominant frequency of atrial fibrillation in humans
  151. Structural bases for the different anti-fibrillatory effects of chloroquine and quinidine
  152. A Major Role for hERG in Determining Frequency of Reentry in Neonatal Rat Ventricular Myocyte Monolayer
  153. Deja vu in the theories of atrial fibrillation dynamics
  154. Targeting atrioventricular differences in ion channel properties for terminating acute atrial fibrillation in pigs
  155. Purkinje cell calcium dysregulation is the cellular mechanism that underlies catecholaminergic polymorphic ventricular tachycardia
  156. Epicardial neural ganglionated plexus of ovine heart: Anatomic basis for experimental cardiac electrophysiology and nerve protective cardiac surgery
  157. Specific residues of the cytoplasmic domains of cardiac inward rectifier potassium channels are effective antifibrillatory targets
  158. Mechanisms Underlying the Antifibrillatory Action of Hyperkalemia in Guinea Pig Hearts
  159. Letter by Berenfeld and Jalife Regarding Article “Dominant Frequency of Atrial Fibrillation Correlates Poorly With Atrial Fibrillation Cycle Length”
  160. Inward rectifier potassium channels control rotor frequency in ventricular fibrillation
  161. Complex fractionated atrial electrograms: Properties of time-domain versus frequency-domain methods
  162. Left versus right atrial difference in dominant frequency, K+ channel transcripts, and fibrosis in patients developing atrial fibrillation after cardiac surgery
  163. Paroxysmal atrioventricular block: Are phase 3 and phase 4 block mechanisms or misnomers?
  164. Mechanisms of stretch-induced atrial fibrillation in the presence and the absence of adrenocholinergic stimulation: Interplay between rotors and focal discharges
  165. A Single-Cell Model of Phase-Driven Control of Ventricular Fibrillation Frequency
  166. Prevention of Atrial Fibrillation
  167. Nerve Supply of the Human Pulmonary Veins: An Anatomical Study
  168. Real-time dominant frequency mapping and ablation of dominant frequency sites in atrial fibrillation with left-to-right frequency gradients predicts long-term maintenance of sinus rhythm
  169. Electrotonic Myofibroblast-to-Myocyte Coupling Increases Propensity to Reentrant Arrhythmias in Two-Dimensional Cardiac Monolayers
  170. Reentry in an accessory atrioventricular pathway as a trigger for atrial fibrillation initiation in manifest Wolff-Parkinson-White syndrome: A matter of reflection?
  171. RXP-E
  172. Atrial Septopulmonary Bundle of the Posterior Left Atrium Provides a Substrate for Atrial Fibrillation Initiation in a Model of Vagally Mediated Pulmonary Vein Tachycardia of the Structurally Normal Heart
  173. Role of Conduction Velocity Restitution and Short-Term Memory in the Development of Action Potential Duration Alternans in Isolated Rabbit Hearts
  174. Cardiac fibrillation: From ion channels to rotors in the human heart
  175. Universal scaling law of electrical turbulence in the mammalian heart
  176. Spatial Distribution of Fibrosis Governs Fibrillation Wave Dynamics in the Posterior Left Atrium During Heart Failure
  177. Arrhythmogenic Mechanisms in a Mouse Model of Catecholaminergic Polymorphic Ventricular Tachycardia
  178. Three distinct phases of VF during global ischemia in the isolated blood-perfused pig heart
  179. Adenoviral Expression of I Ks Contributes to Wavebreak and Fibrillatory Conduction in Neonatal Rat Ventricular Cardiomyocyte Monolayers
  180. Endoscopic fluorescence mapping of the left atrium: A novel experimental approach for high resolution endocardial mapping in the intact heart
  181. Optical mapping of Langendorff-perfused human hearts: establishing a model for the study of ventricular fibrillation in humans
  182. Reentry and atrial fibrillation
  183. Aging and atrial fibrillation research: Where we are and where we should go
  184. Up‐regulation of the inward rectifier K+ current (IK1) in the mouse heart accelerates and stabilizes rotors
  185. Activation of Inward Rectifier Potassium Channels Accelerates Atrial Fibrillation in Humans
  186. Action Potential Duration Restitution Portraits of Mammalian Ventricular Myocytes: Role of Calcium Current
  187. Tiempo, espacio y frecuencia en la fibrilación ventricular
  188. Mechanisms of Wave Fractionation at Boundaries of High-Frequency Excitation in the Posterior Left Atrium of the Isolated Sheep Heart During Atrial Fibrillation
  189. Altered Right Atrial Excitation and Propagation in Connexin40 Knockout Mice
  190. Spectral Analysis Identifies Sites of High-Frequency Activity Maintaining Atrial Fibrillation in Humans
  191. Ionic Determinants of Functional Reentry in a 2-D Model of Human Atrial Cells During Simulated Chronic Atrial Fibrillation
  192. Ionic mechanisms of wavebreak in fibrillation
  193. A Novel Form of Short QT Syndrome (SQT3) Is Caused by a Mutation in the KCNJ2 Gene
  194. Mechanisms of Atrial Fibrillation Termination by Pure Sodium Channel Blockade in an Ionically-Realistic Mathematical Model
  195. The inward rectifier current (IK1) controls cardiac excitability and is involved in arrhythmogenesis
  196. Atrioventricular conduction in mammalian species: Hemodynamic and electrical scaling
  197. Effect of remodelling, stretch and ischaemia on ventricular fibrillation frequency and dynamics in a heart failure model
  198. From Mouse to Whale
  199. Molecular mechanisms and global dynamics of fibrillation: an integrative approach to the underlying basis of vortex-like reentry
  200. Swapping Connexin Genes
  201. Cholinergic atrial fibrillation: IK,ACh gradients determine unequal left/right atrial frequencies and rotor dynamics
  202. Proceedings of the Third International Workshop on Computer Simulation and Experimental Assessment of Cardiac Electrical Function
  203. Synthesis of Voltage-Sensitive Fluorescence Signals from Three-Dimensional Myocardial Activation Patterns
  204. Intra-Atrial Pressure Increases Rate and Organization of Waves Emanating From the Superior Pulmonary Veins During Atrial Fibrillation
  205. Blockade of the Inward Rectifying Potassium Current Terminates Ventricular Fibrillation in the Guinea Pig Heart
  206. Wavebreak Formation During Ventricular Fibrillation in the Isolated, Regionally Ischemic Pig Heart
  207. WAVES IN EXCITABLE MEDIA: EFFECTS OF WAVE GEOMETRY
  208. Frequency-Dependent Breakdown of Wave Propagation Into Fibrillatory Conduction Across the Pectinate Muscle Network in the Isolated Sheep Right Atrium
  209. Minimal principle for rotor filaments
  210. Mother rotors and fibrillatory conduction: a mechanism of atrial fibrillation
  211. Rectification of the Background Potassium Current
  212. New approaches to antiarrhythmic therapy; emerging therapeutic applications of the cell biology of cardiac arrhythmias
  213. Standing Excitation Waves in the Heart Induced by Strong Alternating Electric Fields
  214. Report of the NASPE/NHLBI Round Table on Future Research Directions in Atrial Fibrillation
  215. Action Potential Characteristics and Arrhythmogenic Properties of the Cardiac Conduction System of the Murine Heart
  216. Null Mutation of Connexin43 Causes Slow Propagation of Ventricular Activation in the Late Stages of Mouse Embryonic Development
  217. Shaping of a scroll wave filament by cardiac fibers
  218. Mechanisms underlying ventricular tachycardia and its transition to ventricular fibrillation in the structurally normal heart